Hedge fund that bought Covid vaccine maker Vaxart low, sold high, exits board
Armistice Capital bought pre-Covid shares of Vaxart for little more than a quarter and became the largest institutional shareholder. Now with the fund's stake at less than a 1% stake, its two representatives are leaving the board.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.